ECTRIMS 2021 – ePoster.

Předmět:
Zdroj: Multiple Sclerosis Journal; Oct2021 Suppelemt, Vol. 27, p134-740, 607p
Abstrakt: Further, reduced MRI monitoring in "naSPMS" patients in the real world is a concern, which decreases the chance to detect and treat any new disease activity in these patients. In the past 12 months, aSPMS (vs naSPMS) patients had a lower mean Expanded Disability Status Scale score (4.6 vs 5.2), a higher proportion of patients undergoing MRI (87.7% vs 58.7%), and more MRIs per patient (1.24 vs 0.87). Disease activity (aSPMS) was defined on the basis of MRI lesions (59.1%), relapse status (12.6%), and both MRI and relapse (28.3%). [Extracted from the article]
Databáze: Complementary Index